Technion Laboratory of Cancer Biology and Cannabinoid Research

Located on the campus of Israel’s prestigious Technion Institute of Technology, the Laboratory of Cancer Biology and Cannabinoid Research utilizes the Technion’s resources to “ask and answer almost any question in the field of medical cannabis.”

The lab is devoted to examining the therapeutic potential of cannabinoids and how they can affect illnesses including cancer, epilepsy, and diabetes. The lab also collaborates with cannabis growers, clinicians, and distributors to “revolutionize cannabis treatment on all levels.”

A major project underway at the lab is the creation of a medical cannabis patient database and a cannabis strain database. The patient database is meant to help follow up on patients who have been prescribed cannabis according to their patient class (disease, age, gender, medical data, etc.) in order “to identify patient-class specific treatments and organize them into an accessible website for patients and physicians.”

The strain database is an effort to analyze every strain grown in Israel “to derive optimized treatment options thereby maximizing disease specific therapeutic efficacy while minimizing side-effects.”

The lab has also drawn media coverage for its research that has shown that certain cannabis extracts can kill tumor cells.